Loading
Latest filing published 29 Dec 2021 for Dicerna Pharmaceuticals Inc, €113k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Stephen K. Doberstein on record concern Dicerna Pharmaceuticals Inc. Between 3 June 2021 and 28 December 2021, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 29 December 2021 with a transaction (€113k) in Dicerna Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations